Loading interface...

Pressclav (500/125 mg) Tablet

Manufactured byVeritaz Healthcare Ltd.
ContainsAmoxycillin (500 mg) + Clavulanic Acid (125 mg)
Description
Pressclav (500/125 mg) Tablet is a combination of Amoxycillin and Clavulanic Acid. It is used for the treatment of bacterial infections that affect the ears, lungs, nose, urinary tract, skin, bones, etc. This medication is effective only for the treatment of infections caused by bacteria and not viruses. Pressclav (500/125 mg) Tablet is effective against a large number of bacteria. Amoxycillin works by preventing the formation of bacterial cell walls and killing the infection-causing bacteria. Clavulanic acid prevents bacteria from destroying Amoxycillin and ensures extended anti-bacterial activity. Pressclav (500/125 mg) Tablet may cause some less common side effects such as skin rash, headache, dizziness, skin rash/itching, etc. Consult your doctor if these symptoms persist or if they become severe. Pressclav (500/125 mg) Tablet should be taken as prescribed by your doctor. You will start to feel better in a few days. However, continue taking the medicine for the prescribed duration. Skipping doses or not completing the full course of therapy may result in decreased effectiveness of the medicine or increased risk of re-infection that would be difficult to treat in the future. Pressclav (500/125 mg) Tablet is not recommended if you are allergic to it. Inform your doctor if you have any kidney/liver problems before starting treatment with this medicine. Inform your doctor if you are pregnant or are breastfeeding if this medicine has been prescribed to you.

Side effects

Major & minor side effects for Pressclav (500/125 mg) Tablet

  • Diarrhoea
  • Nausea or Vomiting
  • Skin rash and itching
  • Indigestion
  • Dizziness
  • Headache
  • Thrush (a yeast infection of the vagina, mouth or skin folds)
  • Joint pain
  • Heavy menstrual bleeding

Uses of Pressclav (500/125 mg) Tablet

What is it prescribed for?

  • Community acquired pneumonia
  • Bronchitis
  • Acute bacterial otitis media
  • Pyelonephritis
  • Sinusitis
  • Skin and Soft tissue infections
  • Urinary Tract Infection
  • Osteomyelitis
  • Pharyngitis/Tonsilitis
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Pressclav (500/125 mg) Tablet can be observed within 1-2 hours after taking it.
  • How long do the effects of this medicine last?
    The effect of Pressclav (500/125 mg) Tablet lasts for an average duration of 6-8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies have been reported with Pressclav (500/125 mg) Tablet.
  • Can this medicine be taken during pregnancy?
    Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus is not known. If you are pregnant, take Pressclav (500/125 mg) Tablet only if prescribed by your doctor.
  • Can this medicine be taken while breast-feeding?
    Pressclav (500/125 mg) Tablet passes into breast milk and may cause diarrhoea in your breastfed infant. If you are breastfeeding, consult your doctor.

Allergy

Avoid taking Pressclav (500/125 mg) Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of your face/tongue/throat), severe dizziness, breathing difficulty, etc.

Liver impairment

Pressclav (500/125 mg) Tablet is not recommended if you have a history of liver problems or jaundice (yellowing of the skin) with this medicine due to the increased risk of worsening your condition.
Warnings for special population

Pregnancy

Due to a lack of safety and efficacy studies in pregnant women, the risk to your developing foetus is not known. If you are pregnant, take Pressclav (500/125 mg) Tablet only if prescribed by your doctor.

Breast-feeding

Pressclav (500/125 mg) Tablet passes into breast milk and may cause diarrhoea in your breastfed infant. If you are breastfeeding, consult your doctor.
General warnings

Antibiotic resistance

Antibiotic resistance is a condition in which the antibiotic is not effective against the bacteria. This can be avoided by following the dose and duration of Pressclav (500/125 mg) Tablet as prescribed by your doctor. Finish the entire course of treatment even if your symptoms get better. Alternatively, if your symptoms do not get better even after the prescribed duration, consult your doctor.

Driving or operating a machine

Pressclav (500/125 mg) Tablet is not known to affect your ability to drive or operate machines. However, avoid driving vehicles or operating machines if you experience dizziness.

Use in children

Children below 6 years of age and/or weighing less than 25 kg should preferably be treated with Pressclav (500/125 mg) Tablet suspension or paediatric sachets.

Missed Dose

Try not to skip a dose of Pressclav (500/125 mg) Tablet. Take the missed dose as soon as you remember. If it is time for your next dose, skip the missed dose. Do not double the dose to compensate for a missed one.

Overdose

Do not take excess dose than prescribed by your doctor. Contact your doctor if you suspect an overdose with Pressclav (500/125 mg) Tablet.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Doxycycline

Methotrexate

Warfarin

Ethinyl Estradiol

Live vaccines

Disease interactions

Mononucleosis

Mononucleosis is a viral infection that may result in a sore throat, fever, fatigue, rash, etc. Pressclav (500/125 mg) Tablet is not recommended if you have been infected with mononucleosis as you may develop a maculopapular skin rash (flat and small raised bumps on the skin) 5-10 days after starting treatment with this medicine. The rash resolves within days of discontinuing this medicine.

Kidney Disease

Pressclav (500/125 mg) Tablet should be used with caution if you have pre-existing kidney problems due to the increased risk of side effects. Periodic monitoring of your kidney function is recommended. You may require dose adjustments based on your clinical condition.

Colitis

Pressclav (500/125 mg) Tablet can kill the helpful bacteria in your stomach or intestine and leads to diarrhoea. Therefore, use this medicine with extreme caution if you have colitis (swelling of inner lining of your colon).
Food interactions
Information not available.
Lab interactions

Urine Sugar Test (Benedict's or Fehling's reagent)

Report the use of Pressclav (500/125 mg) Tablet prior to the test. This medicine may give a false-positive result for the presence of glucose/sugar in the urine. The urine sugar test should be performed with a different reagent in case you are receiving this medicine.
Take Pressclav (500/125 mg) Tablet with or after food. Do not take more or less than the prescribed dose. Complete your entire course of treatment and do not stop the use of this medicine without consulting your doctor. Pressclav (500/125 mg) Tablet may cause diarrhoea. Consult your doctor if you experience a severe worsening of your condition. Do not give Pressclav (500/125 mg) Tablet to other people even if their condition appears to be the same as yours. Do not drive or operate machines after taking Pressclav (500/125 mg) Tablet, if you experience dizziness.
Miscelleneous

To be taken with food

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Pressclav (500/125 mg) Tablet is a combination of Amoxycillin and Clavulanic acid. Amoxycillin works by preventing the formation of bacterial cell walls, the outer covering required for cells to stay alive and thereby effectively killing the bacteria. Clavulanic acid works by preventing bacteria from destroying Amoxycillin. Thus, this combination is effective against an extended range of bacteria.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Beta-lactamase inhibitors, Aminopenicillins, Penicillin Beta-Lactam Antibiotics

Schedule

Schedule H

Drugs, H., 2021. Amoxicillin and Clavulanic Acid: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 16 September 2021].

https://medlineplus.gov/druginfo/meds/a685024.html>

Medicines.org.uk. 2021. Augmentin 625mg Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 16 September 2021].

https://www.medicines.org.uk/emc/product/281/smpc>

Medicines.org.uk. 2021. [online] Available at: < [Accessed 16 September 2021].

https://www.medicines.org.uk/emc/files/pil.281.pdf>

Accessdata.fda.gov. 2021. [online] Available at: < [Accessed 16 September 2021].

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050575s037550597s044050725s025050726s019lbl.pdf>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 11 Nov 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.